These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18056788)

  • 21. Glucagon-like peptide 2 inhibits ghrelin secretion in humans.
    Banasch M; Bulut K; Hagemann D; Schrader H; Holst JJ; Schmidt WE; Meier JJ
    Regul Pept; 2006 Dec; 137(3):173-8. PubMed ID: 16928403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A model of controlled acute hyperglycemia in rats: Effects of insulin and glucagon-like peptide-1 analog.
    Saha JK; Xia J; Engle SK; Chen YF; Glaesner W; Jakubowski JA
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1159-64. PubMed ID: 16280413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans.
    Meier JJ; Gethmann A; Nauck MA; Götze O; Schmitz F; Deacon CF; Gallwitz B; Schmidt WE; Holst JJ
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1118-23. PubMed ID: 16403774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effect of portal glucose and glucagon-like peptide-1 to lower systemic glucose and stimulate counter-regulatory hormones.
    Ionut V; Hucking K; Liberty IF; Bergman RN
    Diabetologia; 2005 May; 48(5):967-75. PubMed ID: 15830188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of vagal cooling on canine hepatic glucose metabolism in the presence of hyperglycemia of peripheral origin.
    DiCostanzo CA; Dardevet DP; Williams PE; Moore MC; Hastings JR; Neal DW; Cherrington AD
    Metabolism; 2007 Jun; 56(6):814-24. PubMed ID: 17512315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic portal venous delivery of a nitric oxide synthase inhibitor enhances net hepatic glucose uptake.
    Moore MC; Dicostanzo CA; Smith MS; Farmer B; Rodewald TD; Neal DW; Williams PE; Cherrington AD
    Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E768-77. PubMed ID: 18212022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs.
    Ishida T; Chap Z; Chou J; Lewis R; Hartley C; Entman M; Field JB
    J Clin Invest; 1983 Aug; 72(2):590-601. PubMed ID: 6348094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas.
    Sekigami T; Shimoda S; Nishida K; Matsuo Y; Ichimori S; Ichinose K; Shichiri M; Sakakida M; Araki E
    J Artif Organs; 2004; 7(2):91-100. PubMed ID: 15309676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of chronic fructose infusion on hepatic metabolism during TPN administration.
    Donmoyer CM; Lacy DB; Zhang Y; Chen SS; McGuinness OP
    Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1151-8. PubMed ID: 12424103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Portal 5-hydroxytryptophan infusion enhances glucose disposal in conscious dogs.
    Moore MC; Kimura K; Shibata H; Honjoh T; Saito M; Everett CA; Smith MS; Cherrington AD
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E225-31. PubMed ID: 15755767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inclusion of low amounts of fructose with an intraduodenal glucose load markedly reduces postprandial hyperglycemia and hyperinsulinemia in the conscious dog.
    Shiota M; Moore MC; Galassetti P; Monohan M; Neal DW; Shulman GI; Cherrington AD
    Diabetes; 2002 Feb; 51(2):469-78. PubMed ID: 11812757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects.
    Lerche S; Soendergaard L; Rungby J; Moeller N; Holst JJ; Schmitz OE; Brock B
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):500-6. PubMed ID: 19094067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importance of the hepatic arterial glucose level in generation of the portal signal in conscious dogs.
    Hsieh PS; Moore MC; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E284-92. PubMed ID: 10913027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucagon-like peptide-1 reduces the pulsatile component of testosterone secretion in healthy males.
    Jeibmann A; Zahedi S; Simoni M; Nieschlag E; Byrne MM
    Eur J Clin Invest; 2005 Sep; 35(9):565-72. PubMed ID: 16128863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid translocation of hepatic glucokinase in response to intraduodenal glucose infusion and changes in plasma glucose and insulin in conscious rats.
    Chu CA; Fujimoto Y; Igawa K; Grimsby J; Grippo JF; Magnuson MA; Cherrington AD; Shiota M
    Am J Physiol Gastrointest Liver Physiol; 2004 Apr; 286(4):G627-34. PubMed ID: 14656711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin secretion-independent effects of GLP-1 on canine liver glucose metabolism do not involve portal vein GLP-1 receptors.
    Dardevet D; Moore MC; DiCostanzo CA; Farmer B; Neal DW; Snead W; Lautz M; Cherrington AD
    Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G806-14. PubMed ID: 16051922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiological changes in circulating glucagon alter hepatic glucose disposition during portal glucose delivery.
    Holste LC; Connolly CC; Moore MC; Neal DW; Cherrington AD
    Am J Physiol; 1997 Sep; 273(3 Pt 1):E488-96. PubMed ID: 9316437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A negative arterial-portal venous glucose gradient increases net hepatic glucose uptake in euglycemic dogs.
    Galassetti P; Chu CA; Neal DW; Reed GW; Wasserman DH; Cherrington AD
    Am J Physiol; 1999 Jul; 277(1):E126-34. PubMed ID: 10409136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined intraportal infusion of acetylcholine and adrenergic blockers augments net hepatic glucose uptake.
    Shiota M; Jackson P; Galassetti P; Scott M; Neal DW; Cherrington AD
    Am J Physiol Endocrinol Metab; 2000 Mar; 278(3):E544-52. PubMed ID: 10710510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orally administered glucagon-like peptide-1 affects glucose homeostasis following an oral glucose tolerance test in healthy male subjects.
    Steinert RE; Poller B; Castelli MC; Friedman K; Huber AR; Drewe J; Beglinger C
    Clin Pharmacol Ther; 2009 Dec; 86(6):644-50. PubMed ID: 19727071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.